CALL FOR PAPERS Microbial-Linked Diseases

Cambridge Healthtech Institute chi at healthtech.com
Wed Jan 28 11:29:15 EST 1998


FIRST ANNOUNCEMENT AND CALL FOR PAPERS

Cambridge Healthtech Institute's First International
Microbial-Linked Diseases: Shifting the Pathogenic Paradigm 
June 25-26, 1998  Westin Horton Plaza  San Diego, CA 

Sensitive new diagnostic tools and observant microbiologists are
increasingly identifying diseases for which infectious agents play a
role in causation or exacerbation. These are diseases such as cancer,
autoimmune diseases and cardiovascular conditions which are
traditionally not envisioned as transmittable. The discovery that
infectious agents are involved can have a dramatic impact on the
understanding, diagnosis and treatment of patients with these
diseases. Researchers involved with pathogenesis, virulence factors,
host susceptibility or resistance, immune mechanisms, identification,
cloning and sequencing research, genetic studies, viruses, prokaryotic
organisms and protozoa are encouraged to submit a brief description
detailing their work (approaches) for consideration of presentation.
Also, we would most appreciate your suggestions of colleagues or other
people you would like to hear, who might be suitable/interested in
speaking and what types of research/approaches they are currently
involved in.  

SESSION TOPICS PROPOSED:

Pathogens: 
H. Pylori link to stomach cancers 
Human Papilloma Virus (HPV) and Cervical Cancer, Genital Warts and
other STDs
Herpesvirus link to MS (HHV-6)
Chlamydia and Cardiovascular diseases (i.e. Atherosclerosis) 
HHV-8 link to Epstein-Barr virus (EBV)and cytokine receptor genes 
and Kaposi's sarcoma
EBV link with Burkitt's lymphoma and nasopharyngeal carcinoma 
Endogenous retroviruses as pathogenic catalysts for disease
Molecular Mimicry-structural homologies between a self protein and a
viral or bacterial protein
CMV-linked arterial plaque formation
Mycoplasma as a proposed causative agent of RA

Diagnostic Markers:
Defensive vs. 'Memory' Antibodies as pathogenic markers

Therapeutic and Vaccine Development:
H.  Pylori vaccine development 
HPV-6, HPV-11, HPV-16 and HPV-18 

Deadline for Submission is February 20, 1998.

Please submit abstract by fax or e-mail to: 
Carol S. Sussman, Conference Director
Phone: 617-630-1348  Fax: 617-630-1325
e-mail: csussman at healthtech.com
______________________________
Cambridge Healthtech Institute      
1037 Chestnut Street
Newton Upper Falls, MA  02164
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
tel: 617.630.1300
fax: 617.630.1325
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
inquiries at healthtech.com
World Wide Web http://www.healthtech.com/conferences




More information about the Immuno mailing list